DeepMed Research

MEDICAL COLLEGE OF WISCONSIN

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1893-01-01

Employees: 5K

Market Cap: -

Website: http://www.mcw.edu

Clinical Trials

Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy

Phase 4

Terminated

Conditions: Cardiac Amyloidosis

Interventions: Drug: F18 Florbetapir (amyvid) cardiac PET/CT imaging

First Posted Date: 2017-11-07

Last Posted Date: 2023-05-09

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 3

Registration Number: NCT03333551

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial

Phase 2

Recruiting

Conditions: Pancreatic Cancer

Interventions: Drug: First-line Chemotherapy
Drug: Second-line Chemotherapy
Radiation: Chemoradiation

First Posted Date: 2017-10-26

Last Posted Date: 2024-11-21

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 125

Registration Number: NCT03322995

Locations: 🇺🇸
Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Assessment of Optune Therapy for Patients with Newly Diagnosed Glioblastoma Using Advanced MRI

Recruiting

Conditions: Glioblastoma

Interventions: Device: Standard Magnetic Resonance Imaging (MRI)
Device: Advanced MRI.

First Posted Date: 2017-09-29

Last Posted Date: 2025-02-25

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 60

Registration Number: NCT03297125

Locations: 🇺🇸
Froedtert Hospital & Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Effect of Probiotic Supplementation on Endothelial Function II

Not Applicable

Recruiting

Conditions: Diabetes Mellitus, Type 2
Cardiovascular Disease

Interventions: Dietary Supplement: Goodbelly first
Dietary Supplement: Placebo first

First Posted Date: 2017-08-30

Last Posted Date: 2025-03-13

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 215

Registration Number: NCT03267758

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)

Phase 2

Completed

Conditions: Sickle Cell Disease

Interventions: Procedure: Haploidentical Bone Marrow Transplantation
Drug: Hydroxyurea
Drug: Rabbit-ATG
Drug: Thiotepa
Drug: Fludarabine
Drug: Cyclophosphamide
Radiation: Total Body Irradiation
Drug: Mesna

First Posted Date: 2017-08-28

Last Posted Date: 2025-04-27

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 95

Registration Number: NCT03263559

Locations: 🇺🇸
Texas Children's Hospital (Baylor), Houston, Texas, United States
🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
🇺🇸
Nicklaus Children's Hospital/University of Miami Children's Hospital, Miami, Florida, United States

and more 29 locations

Stay on Track: A Study of Exercise Effects During Radiation

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Lifestyle- Supportive Care

First Posted Date: 2017-08-09

Last Posted Date: 2021-11-30

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 47

Registration Number: NCT03243786

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Counseling for Prematurity Using a Multimedia Education Tool

Not Applicable

Completed

Conditions: Premature Birth
Infant, Premature
Resuscitation
Counseling
Prenatal Care
Decision Making

Interventions: Other: Printed Handout
Other: Multimedia Information

First Posted Date: 2017-07-21

Last Posted Date: 2019-02-27

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 76

Registration Number: NCT03225885

Locations: 🇺🇸
Froedtert Hospital, Milwaukee, Wisconsin, United States

Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer
Invasive Breast Cancer

Interventions: Drug: Anastrozole
Drug: Letrozole
Drug: Exemestane
Drug: Tamoxifen

First Posted Date: 2017-07-17

Last Posted Date: 2025-04-29

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 37

Registration Number: NCT03219476

Locations: 🇺🇸
Froedtert Hospital, Milwaukee, Wisconsin, United States

Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

Completed

Conditions: Multiple Myeloma
Bone Marrow Transplant Complications

Interventions: Procedure: Autologous hematopoietic cell transplant

First Posted Date: 2017-06-27

Last Posted Date: 2023-03-28

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 750

Registration Number: NCT03200626

Locations: 🇺🇸
Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin, United States

NovoTTF Treatment Signatures in Glioblastoma Patients At Autopsy

Recruiting

Conditions: Glioblastoma

Interventions: Device: Tumor samples from patients treated with TTFields at tumor recurrence.
Other: Tumor samples from patients treated with TTFields at initial diagnosis.

First Posted Date: 2017-06-21

Last Posted Date: 2025-02-26

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 20

Registration Number: NCT03194971

Locations: 🇺🇸
Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy